Historical beginnings
A chicken tumour sample originally collected in the 1930s by Albert Claude at the Rockefeller Institute in New York was ®nally, in the 1980s,`recycled' by Bruce Mayer, a graduate student from the laboratory of Saburo Hanafusa, in the search for novel oncogenes (Mayer et al., 1988) . Surprisingly, the ®brosarcoma-inducing oncogene identi®ed from this tumour material did not contain an oncogene with recognizable catalytic activity, but rather encoded for a fusion gene of the viral gag gene (which encodes major structural proteins of the virion) and a cellular gene which encodes two domains, initially only recognized by their homology to regions of other signalling proteins like non-receptor tyrosine kinases and phospholipase C-g.
Despite the absence of an apparent catalytic domain in the oncogene, Mayer and colleagues noted a remarkable increase of tyrosine-phosphorylated proteins in chicken embryo ®broblasts transformed by this virus. This seemed to suggest that the new oncogene was activating a cellular tyrosine kinase and led to the name crk (for chicken tumour virus no. 10 [CT10] regulator of kinase; Mayer et al., 1988) .
Shortly after the v-crk gene was isolated from the CT10 retrovirus, an independent viral isolate named avian sarcoma virus 1 (ASV-1; Tsuchie et al., 1989) was found to contain a nearly identical oncogene. Both oncoproteins dier only in a few amino acids, which do not appear to be crucial for the biological potency of the tumor virus, although a direct comparison of both oncogenes has not been published and ultrastructural data do suggest signi®cant dierences in protein binding properties (Wu et al., 1995; discussed further below) . Only a single study so far used cells carrying the ASV-1 or CT10 oncogenes side-by-side (Sakai et al., 1994b) . However, these cells were from dierent species and the focus of the study was on the puri®cation of a v-Crk associated phosphotyrosylprotein, now known as p130Cas.
Following the sequencing of the cellular cDNA of chicken Crk (Reichman et al., 1992) , Crk family adaptor cDNAs have been sequenced from dierent higher eukaryotes (Matsuda et al., 1992; KizakaKondoh et al., 1996; Evans et al., 1997; Galletta et al., 1999; Reddien and Horvitz, 2000) . Human and mouse Crk-like (CRKL), the products of Crk-homologous but distinct genes, were also cloned shortly after the ®rst c-Crk sequences had been published (ten Hoeve et al., 1993; de Jong et al., 1995a ). An alignment of most protein sequences can be found in Galletta et al. (1999) . Unlike CRKL, c-Crk is expressed as two distinct proteins of 28 and 40 kDa, respectively (Matsuda et al., 1992) . c-Crk I consists of one SH2 and one SH3 domain, while c-Crk II has an additional SH3 domain separated by a`spacer region' of approximately 60 amino acids.
Identi®cation of the viral Crk oncoprotein (v-Crk; p47 gag ± crk ) and cloning of its cellular counterparts, as well as the subsequent analyses of their biological roles, fundamentally changed our view on intracellular signal transduction. It became clear that the transmission of signals within cells heavily relies on the formation of protein complexes which are based on selective protein domain interactions (Pawson, 1995; Bork et al., 1997; Pawson and Scott, 1997; Pawson and Nash, 2000) .
Very early on, it was shown that the CT10-derived vCrk protein associates with`type I' phosphatidylinositol (PI) kinase activity (Fukui et al., 1989) although these experiments have not been followed-up much until quite recently (Akagi et al., 2000) , and there is at present no evidence in the literature indicating that the activation of tyrosine kinase(s) by v-Crk critically depends on the action of PI3 kinase.
However, it was rapidly noted that v-Crk forms stable complexes with two prominent tyrosine-phosphorylated proteins of 70 and 135 kDa in CT10-infected chicken ®broblasts (Mayer et al., 1988 ; details to follow). Since then, the identi®cation of these and other Crk/CRKL binding proteins has greatly improved our insight into the components and functional details of the cellular signalling machinery.
Several reviews have so far discussed the accumulated knowledge or certain aspects of Crk family adaptors (Feller et al., 1994a Birge et al., 1996; Kiyokawa et al., 1997; Sattler and Salgia, 1998; Buday, 1999; Kolibaba et al., 1999; Platanias and Fish, 1999; Stupack et al., 2000; Furge et al., 2000; Voss et al., 2001) . However, Crk family proteins continue to be a focus of considerable research activity, with over one hundred new studies published per year on their various isoforms, homologues and binding partners. In the last few years major advances in understanding the biological function of Crk adaptors have been made, for example through the analysis of genetic model systems like C. elegans and Drosophila and, most recently, the targeted disruption of the crkl gene locus in the mouse (Guris et al., 2001) . This review's aim is to summarize key ®ndings and to highlight recent progress in understanding the biological functions, binding proteins and mechanistic details of Crk adaptor signal transmission.
Protein ± protein interaction domains
A comparison of the amino acid sequences of Crk family adaptors (Galletta et al., 1999) shows a high homology between the family members c-Crk and CRKL, as well as between dierent eukaryotic species within the regions of the protein now widely known as Src homology 2 and 3 (SH2 and SH3) domains. These domains are globular protein interaction modules found in many cellular proteins (Musacchio et al., 1994; Pawson, 1995; Cohen et al., 1995; Kuriyan and Cowburn, 1997; Mayer and Gupta, 1998) . They were initially discovered by homology comparision (Sadowski et al., 1986; Mayer et al., 1988) . The N-and Ctermini of these domains are in close proximity, which allowed them throughout evolution to be newly inserted into proteins without too much disruption of the overall protein structures. SH2 and SH3 domains are also the almost exclusive building blocks of a group of small adaptor proteins, which includes in addition to the Crk and CRKL proteins the Grb2 and Nck adaptor families, known to play important roles in the regulation of cell proliferation, dierentiation, immune receptor signalling etc. (Li and She, 2000; Norian and Koretzky, 2000; Li, 2001, this issue; McGlade, 2001 , this issue; for domain composition of small SH2/SH3 adaptors see Feller et al., 1998) . The SH2 domains of these adaptors are often the connection to the upstream partner(s) within a signalling cascade, while SH3 domains serve in many cases to couple a protein to its eector(s).
SH2
SH2 domains bind to protein motifs which usually contain a phosphorylated tyrosine residue followed by speci®c residues (often in positions +2 to +5). The SH2 domain interacting with tyrosine-phosphorylated proteins was ®rst recognized through the analysis of the v-Crk protein, which stably associates with heavily tyrosine-phosphorylated proteins in v-Crk-transformed ®broblasts (Mayer et al., 1988; Mayer and Hanafusa, 1990; Matsuda et al., 1990 Matsuda et al., , 1991 . Those ®ndings were rapidly con®rmed for other SH2 domains by many subsequent studies. One hundred and nineteen genes with SH2 domains exist in the human genome according to one study (Lander et al., 2001 ) while another predicts a minimum of 141 (SMART program, EMBL website; Schultz et al., 2000) . For the Crk SH2 domain the preferred binding motif is pY-x-x-P. This preference was initially identi®ed by an in vitro approach and subsequently con®rmed by mutational analyses of several Crk SH2 domain binding partners. Multiple pY-x-x-P motifs are present in prominent Crk SH2 binding proteins like paxillin (p70; Birge et al., 1993; Schaller, 2001 , this issue), p130Cas (Sakai et al., 1994a; Bouton, 2001, this issue) and its homologues, the ubiquitin-ligase c-Cbl (p120; Smit and Borst, 1997; Tsygankov, 2001, this issue) and the large docking protein Gab1 (GarciaGuzman et al., 1999; Sakkab et al., 2000) . The binding speci®city of the highly homologous SH2 domains of Crk and CRKL is apparently quite similar and many of the proteins shown to bind to the c-Crk and v-Crk SH2 domains also co-immunoprecipitate with CRKL (de Jong et al., 1995b; Salgia et al., 1995 and others) . Surprisingly, a somewhat dierent binding motif was reported for the Xenopus Crk SH2 domain which recognizes two Y-x-x-L motifs in the apoptosis-inducing cell cycle regulator XWee-1 .
SH3
The ®rst publication implicating SH3 domains as protein ± protein interaction domains, was a report that a protein named 3BP-1 (SH3 binding protein 1) bound to the Abl SH3 domain (Cicchetti et al., 1992) in an expression library screen using the SH3 domain Oncogene Crk family adaptors SM Feller as a probe and in other in vitro binding assays. 3BP-1 is a GTPase-activating protein (GAP) for Rac (Cicchetti et al., 1995) . At present it is believed that the interaction of 3BP-1 with the Abl SH3 domain does not occur in physiological situations. Shortly after the 3BP-1 identi®cation as Abl SH3 binder, it was shown that a short, proline-rich protein fragment of 3BP-1 is necessary and sucient to bind the Abl SH3 domain (Ren et al., 1993) . It is now known that SH3 domains often bind to proline-rich protein motifs and peptides conforming to a core consensus P-x-x-P plus some speci®city-determining additional residue(s) in the vicinity. Nevertheless, some prominent examples are known which deviate from this common theme: the tumour suppressor gene product p53 forms a complex with an SH3-containing protein named p53BP2 (Gorina and Pavletich, 1996) , with the SH3 domain of p53BP2 recognizing a bipartite motif in the`L3-loop' of p53. The SH3 domain of the Eps8 protein, which regulates EGF receptor signalling and tracking (Lanzetti et al., 2000) is apparently only functional as an intertwined SH3 domain dimer (Kishan et al., 1997) and recognizes a P-x-x-D-Y motif (Mongiovi et al., 1999) . Another example is the SH3 domain of the immune cell adaptor FYB (also known as SLAP), which binds a R-K-x-x-Y-x-x-Y motif of SKAP55, yet another immune cell adaptor protein (Kang et al., 2000) . The SH3 domains of the tyrosine kinases Fyn and Lck also bind to this motif, albeit 10-fold weaker. Most recently the Grb2 SH3(C) domain was shown to bind to the core motif P-x-x-x-R-x-x-K-P, which is present in adaptors and large docking proteins like SLP-76, Gab1 and Gab2 and AMSH (Lock et al., 2000; Lewitzky et al., 2001) .
At present more than 800 SH3s and SH3-like domains are contained in the various databases, over 200 in the human genome alone (Lander et al., 2001) . SH3-like folds are not only found in intracellular proteins of eukaryotes but also in extracellular proteins like MIA (Stoll et al., 2001) , in virus genes and even in prokaryotes (Whisstock and Lesk, 1999) . The DNAbinding domain of the HIV-1 integrase has an SH3-like structure (Eijkelenboom et al., 1995; Lodi et al., 1995) . The same is true for the metal binding domain of the cobalt-activated diphtheria toxin repressor-DNA complex (Pohl et al., 1999) .
The binding speci®city of the ®rst SH3 domain of cCrk was unravelled through analysing its complex formation with the highly selective CrkSH3(1) binding protein C3G, a guanine nucleotide releasing protein for the small GTPase Rap1. C3G contains in its central region several motifs which conform to the consensus P-x-x-P-x-K (Knudsen et al., 1994; Tanaka et al., 1994) . Subsequent studies showed that the lysine following in position +2 of the P-x-x-P motif is crucial for the high anity interaction Wu et al., 1995) . The remarkable anity and selectivity created by the lysine residue in the P-x-x-P-x-K motif is explained by the unique structure of the lysine-binding pocket of the Crk SH3(1) domain. The positive charge at the end of the lysine side chain is balanced by three negative residues arranged in a highly symmetric fashion, while the hydrophobic part of the lysine side chain stacks against the hydrophobic ring structure of a tryptophan. Switching the lysine to an arginine not only strongly reduces the anity of the C3G-derived peptide for the SH3 domains of c-Crk and CRKL, but also switches its binding speci®city, thereby generating a core binding motif for the N-terminal SH3(N) domain of the adaptor protein Grb2 and for the second SH3 domain of the adaptor Nck.
In this context it is interesting that the v-Crk protein encoded by the ASV-1 retrovirus has a Crk sequence identical to the chicken c-Crk sequence, while CT10 has several point mutations. A molecularly signi®cant change occurs for example in the`RT-loop' of the CT10 v-Crk SH3(1) domain: glutamic acid 384, one of the three negatively charged residues which make contact to the positive charge of the lysine in the Px-x-P-x-K motif, is changed to glycine. This mutation is predicted to signi®cantly (8 ± 10-fold) weaken the binding of CT10 v-Crk SH3(1) to the P-x-x-P-x-K motif. Moreover, if only two of the three negatively charged residues can make contact to the lysin, the preferential binding of lysine vs arginine is lost, according to computer modelling results (Wu et al., 1995) . Whether this CT10 SH3(1) domain mutation also leads to a switch in the biological pathways used by CT10 vs ASV-1 is not yet studied. Due to the great abundance of viral Crk protein in virus-infected ®broblasts, even such a signi®cant mutation may be more than compensated by sheer mass production of the viral oncoprotein. It is also possible that the crk gene-carrying retroviruses never use c-Crk/CRKLactivated pathways and simply`spill over' into other signalling pathways.
There is at least one other SH3 domain in which a Px-x-P-x-K motif is part of the binding consensus, namely the SH3 domain of the 85 kDa cytoskeletal protein cortactin which localizes to the sites of actin assembly (Sparks et al., 1996; Weaver et al., 2001; reviewed in Weed and Parsons, 2001 , this issue). However, cortactin seems to preferentially recognize sequences which have a proline in position +3 of the core P-x-x-P motif and/or tryptophan and/or leucine in positions +5 and +6 (P-x-x-P-x-K-P-x-W-L; Sparks et al., 1996) . The cortactin SH3 domain does not bind to high anity CrkSH3(1) binding peptides (Oehrl, 1997) but some overlap of CrkSH3(1) and cortactin SH3 binding using in vitro binding assays has been reported (Yamabhai Kay, 1997) . No examples of a biologically relevant competition of the Crk and cortactin SH3 domains for the same binding partner are currently known.
Parrini and Mayer have recently generated a temperature-sensitive version of the CrkSH3(1) domain, which may open new ways of looking at Crk signalling mechanisms (Parrini and Mayer, 1999) . Furthermore, the`tool box' for the analysis of SH3 domains from adaptor proteins like Crk and Grb2 has been extended by the generation of SH3 domain binding peptides in which natural prolines are replaced by non-natural amino acid derivatives (Nguyen et al., 1998 (Nguyen et al., , 2000 Tuchscherer et al., 2001) . These peptides bind with higher anities than the corresponding peptides completely made up of naturally occurring amino acids. In vivo studies with these compounds are still missing, but it is already clear from the current literature that Grb2 and Crk/CRKL SH3 domain blocker peptides can be carried into cells with peptidevector systems, thereby inhibiting adaptor protein signalling (Cussac et al., 1999; Kardinal et al., 2000 Kardinal et al., , 2001 Sakkab et al., 2001) .
Adaptors and enzymes which interact with Crk/CRKL SH2 and SH3 domains p130Cas family Nearly all proteins which interact with the SH2 domain of Crk family adaptors have several to many of the already described Y-x-x-P motifs, which are sometimes clustered within a distinct region of the binding protein (for a structural overview see Sakkab et al., 2000) . This is especially true for the long sought p130Cas protein (130 kDa Crk associated kinase substrate), which is also a prominent substrate of retroviral tyrosine kinase oncoproteins like v-Src, and was ®nally cloned by Sakai et al., in 1994 (Sakai et al., 1994a reviewed in Bouton, 2001 , this issue). In p130Cas no less than 15 Y-x-x-P motifs are clustered within the 260 amino acid substrate region' of the protein. The p130Cas protein family now includes the homologous proteins Hef1/ Cas-L and Efs/Sin (O'Neill et al., 2000) . The overall structural organization of p130Cas-family proteins is quite similar to other large docking proteins like insulin receptor substrates (IRS1 to 4), Gab (Grb2 associated binder) family proteins, their Drosophilarelative Daughter of sevenless (Dos) etc. (see also Schlessinger (2000) for structural compositions). At the N-terminus a single SH3 domain (in the case of Cas family proteins) or a pleckstrin homology (PH) domain (in Gab, IRS and DOS proteins) can be found. They function as protein or phosphatidylinositol interaction domains. In addition there are numerous tyrosines clustered or scattered throughout the proteins which serve as docking sites for various SH2 domains. Besides Crk family adaptors, other adaptors and a variety of enzymes are recruited to these multi-docking-site proteins, including tyrosine kinases of the FAK and Src families, tyrosine phosphatases and, in the case of p130Cas, the Crk SH3(1) domain-binding guanine nucleotide exchange factor C3G which activates the Rap1 GTPase (Kirsch et al., 1998, and references therein) .
The exact nature of the multiprotein complexes assembled on the p130Cas family protein scaolds presumably varies signi®cantly, depending on cell type and stimulus. While the SH2 domain of Crk has a particularly great preference for the proline in position +3 of the phosphotyrosine residue, a considerable number of SH2 domains also display a slight preference for proline in the same position (Abl, Nck etc.; Songyang et al., 1993) . This could lead to competitive situations between several SH2 domaincontaining proteins in vivo unless additional conformational constraints or other not yet well de®ned parameters further specify a certain Y-x-x-P motif for exclusive binding of a single SH2 domain.
For a better understanding of how such large signalling complexes are assembled, coordinated and used to generate speci®c signals, it will be necessary to perform in depth biochemical analyses and reconstitution experiments, similar to studies previously done with equally complex systems, for example the basal transcription machinery. To complicate things, it may be necessary to include membrane and cytoskeletal components or even focal adhesion-like structures into such assays in order to allow the proper assembly of the signalling complexes. These biochemical reconstitution experiments have to be accompanied by the simultaneous observation of multiple tagged proteins in living cells in order to validate in vitro ®ndings in vivo.
Many of the Crk/CRKL ± p130Cas protein family related signalling studies have been summarized elsewhere Sattler and Salgia, 1998; Cary and Guan, 1999; Schlaepfer et al., 1999; O'Neill et al., 2000; Stupack et al., 2000; Bouton, 2001 , this issue). p130Cas-de®cient mice die`in utero' and have severe defects in cardiovascular development and actin reorganization (Honda et al., 1998) . According to a plethora of reports using various cell lines, p130Cas and its siblings play in concert with Crk family adaptors and dierent enzymes a major role in the reorganization of the cytoskeleton during cell shape changes and cell migration (Klemke et al., 1998; Cheresh et al., 1999; and others) and in mediating signal transmission from integrins (Nojima et al., 1995) . Signals from soluble growth factors like bombesin also require Crk ± Cas complexes (Rozengurt, 1998; Posern et al., 2000 , and references therein; see also Table 1 for other factors). Within the year 2000, reports from one group have indicated that the human p130Cas homologue, which they renamed BCAR1, plays a role in the antiestrogen resistance of breast cancer cells (Brinkman et al., 2000; van der Flier et al., 2000a,b) . Also implicated in tamoxifen-resistance of breast cancer cells is BCAR3 (van Agthoven et al., 1998) , which was also cloned under the name of AND-34, binds to p130Cas and is an activator of Ras-like GTPases including Rap1 (Cai et al., 1999; Gotoh et al., 2000) . p130Cas not only binds to AND-34 but was also proposed to regulate its GEF-activity.
Paxillin
Similar to the p130Cas protein family, the 68 ± 70 kDa protein paxillin is a substrate for several normal and oncogenic tyrosine kinases. It is thought to function as a scaold or adaptor to organize signal transduction proteins into a large complex at`focal adhesions', major contact points between plasma membrane and the cytoskeleton and a site of integration for growth and adhesion signals (reviewed in Turner, 2000; Schaller, 2001, this issue) . Paxillin also regulates cell morphology and motility (Nakamura et al., 2000; Petit et al., 2000 and references therein) .
Several p130Cas binding proteins have been reported to also bind to paxillin, including Src and FAK family kinases. p130Cas and paxillin are thought to be physically linked ± at least indirectly ± since they are both parts of a large multiprotein complex (Turner, 2000) . Recent data led to the hypothesis that paxillin and p130Cas may oppose each other functionally in regulating the movement of certain cells (Yano et al., 2000b) . Paxillin is attached to the cell membrane via its C-terminal LIM domains (Dawid et al., 1998) and binds to a 4 -integrins (Liu et al., 1999a) . It also binds to the Arf-GAP protein p95PKL (paxillin ± kinase linker) via a leucine-rich repeat (LD4 motif) which leads to its indirect interaction with PAK (p21 GTPase-activating kinase), Nck and PIX (PAK-interacting exchange factor) .
Moreover, paxillin also contains two motifs (Y31 and Y118) which conform to the Y-x-x-P consensus and are functional Crk/CRKL SH2 domain binding sites (Schaller and Parsons, 1995; Petit et al., 2000) . Binding of c-Crk and CRKL to these sites after their phosphorylation leads to an accumulation of Crk eectors bound via the Crk/CRKL SH3 domains at sites of paxillin abundance. Paxillin is also strongly hyperphosphorylated in v-Crk-transformed cells and was identi®ed as a binding partner of the v-Crk SH2 domain ). It appears in several splice variants which dier at their N-termini. Whether the dierential splicing aects Crk/CRKL binding has yet to be studied. Furthermore, several paxillin-homologous proteins exist, but they do not seem to interact with Crk family adaptors . Paxillin-de®cient mice suer from early embryonic lethality indicating that the other paxillin family genes (Hic-5, leupaxin) have distinct functional roles from paxillin (Turner, 2000) .
Cbl and Cbl-b p120 c-Cbl is another Crk/CRKL SH2 binding protein which forms tyrosine phosphorylation-dependent, inducible or constitutive complexes, depending on the cell type and situation studied (reviewed in Feller et al., 1998; Lupher et al., 1999; and others) . In Abltransformed cells, two phosphorylated Y-x-x-P motifs (Y700, Y774) were identi®ed as the major CRKL SH2 domain docking sites (Andoniou et al., 1996) . T-and B-lymphocytes were found in many studies to phosphorylate c-Cbl and to build complexes of Cbl with dierent adaptor proteins, including Crk and CRKL, upon activation of the T-or B-cell receptors although the function of these complexes is not well understood. Cbl association with CRKL has been suggested to play a role in the maintenance of T-cell non-responsiveness (anergy) which occurs when the Tcell receptor is stimulated in the absence of a costimulus. It is thought that this eect is accomplished by blocking IL-2 action through a TCR ± Cbl ± CRKL ± C3G ± Rap1 pathway (Boussiotis et al., 1997) . However, this ®nding has not yet been further con®rmed by other studies.
Certain cytokines and dierentiation factors, for example erythropoietin (Epo) also lead to Cbl phosphorylation and the formation of Cbl ± CRKL complexes Chin et al., 1997; and others) . More recently, Cbl phosphorylation and complex formation was also reported for non-haematopoietic cells in response to hepatocyte growth factor (HGF)-activation of the c-Met tyrosine kinase receptor and in cells transfected with the transforming fusion protein Tpr-Met (Garcia-Guzman et al., 2000) .
Until two years ago, c-Cbl was believed to be basically a large adaptor protein not unlike p130Cas or paxillin. Then it was discovered that the Ring ®nger (RF) domain of c-Cbl has in fact E3-type ubiquitin ligase activity which plays an important role in the proteolytic down-modulation of cell surface receptor tyrosine kinases by attaching the 76 amino acid polypeptide ubiquitin onto the receptor protein, thereby marking the receptors for proteasomal destruction (Joazeiro et al., 1999; Levkowitz et al., 1999; reviewed in Sawasdikosol et al., 2000) . In other cases, ubiquitination may also have dierent functions, for example to serve as a sorting signal in endocytosis or in DNA repair (Dubiel and Gordon, 1999; Rotin et al., 2000; Jentsch and Pyrowolakis, 2000) . Could c-Crk and/or CRKL serve to present proteins to Cbl for ubiquitination and would this lead to protein degradation or the regulation of endocytosis? No answers to these questions can be given at this point, although p130Cas has recently been reported to function in integrin-mediated endocytic adenovirus entry (Li et al., 2000b) .
Latest studies indicate that Cbl associates with specialized membrane structures called`lipid rafts' upon certain stimuli (Baumann et al., 2000; Lafont and Simons, 2001; Saltiel, 2001) . If, and how this aects or involves Crk adaptor family signalling also remains to be studied. A Cbl-relative, Cbl-b, which was also reported to interact with Crk (Elly et al., 1999) can function as a negative regulator of lipid raft formation in T cells (Krawczyk et al., 2000) .
IRS proteins
The insulin receptor and the IGF-1 receptor phosphorylate upon stimulation a family of multi-site docking proteins which are known as insulin receptor substrate (IRS) proteins and include four members (IRS-1 to IRS-4; recently reviewed in Giovannone et al., 2000; Whitehead et al., 2000; Bevan, 2001; Burks and White, 2001) . As brie¯y mentioned above, IRS proteins are characterized by the presence of Nterminal PH domains which bind to phosphoinositides (Razzini et al., 2000) . These are followed by phosphotyrosine binding (PTB) domains which recognize speci®c phosphotyrosine-containing epitopes, for ex- ample N-x-P-pY motifs present on the insulin and other receptors He et al., 1995; Wolf et al., 1995; Sawka-Verhelle et al., 1996) , thereby anchoring the IRS protein at the receptor. Throughout the rest of the protein, a fairly large number of tyrosyl residues is present which can become phosphorylated upon certain stimuli. IRS proteins bind distinct, if partially overlapping sets of signal transducers including PI3 kinase, SHP2, adaptor proteins like Grb2, Nck, Crk and CRKL and others. They have also been shown to exist in distinct subcellular localizations (Anai et al., 1998; Giovannone et al., 2000) . IRS-1-de®cient mice are quite small, indicating that IRS-1 is important for cell growth. IRS-1(7/7) mice do not succumb to a severe diabetes-like disease (Araki et al., 1994) . By contrast, IRS-2-de®cient mice develop severe hyperglycemia and diabetes early in life, hence IRS-2 appears to be critical for normal carbohydrate metabolism (Withers et al., 1998) . The IRS-3 protein is mainly expressed in adipocytes of white fat tissue, and mice lacking a functional gene for IRS-3 synthesis have no apparent defects in growth or glucose metabolism (Liu et al., 1999b) . The phenotype of IRS-4 knockout mice (Fantin et al., 2000) is relatively mild. A slight growth retardation and minor defects in glucose homeostasis were observed. Taken together, these animal studies document that the IRS family proteins have quite distinct biological roles and functional redundancy does not appear to be a major issue in this protein family. A recent study even suggests that the IRS-3 and IRS-4 proteins can impair rather than complement the signalling of their relatives IRS-1 and -2 (Tsuruzoe et al., 2001) .
Of the four family members, IRS-1 and IRS-4 have so far been shown to interact w. Crk/CRKL (BeitnerJohnson et al., 1996; Sorokin et al., 1998; Koval et al., References in brackets refer to in vitro data, overexpression studies, preliminary ®ndings etc. *Inhibitors of tyrosine phosphatases. (*)Other stimuli also signalling through 7-TM receptors include: bradykinin, endothelin, LPA, vasopression 1998b; Butler et al., 1998; Qu et al., 1999) . If indeed all Crk/CRKL ± IRS complexes are mediated by the direct binding of SH2 domains from Crk family adaptors remains to be established. Although the human IRS-4 does not contain a single Y-x-x-P motif, IRS-4 from IGF-1-stimulated human embryonic kidney (HEK293) cells was reported to bind to the SH2 domains of both c-Crk and CRKL in vitro (Koval et al., 1998b) . On the other hand, rat IRS-3 has three Y-x-x-P motifs (mouse IRS-3 has two) but no evidence for Crk/CRKL SH2 domain binding to IRS-3 is yet published.
The functional consequences of Crk/CRKL complex formation with the IRS-1 and IRS-4 proteins are largely unclear. Since both of these IRS proteins apparantly have some role in regulating cell proliferation, such complexes may act in concert with other well known binders of IRS proteins like PI3 kinase, SHP2 and Grb2 to generate appropriate signals downstream from insulin, IGF-1, PDGF and other growth factors in a speci®c cell context (Sorokin et al., 1998; Nakashima et al., 1999; Qu et al., 1999) . Other roles, for example as a signal mediator in adipocyte dierentiation, have also been recently suggested (Jin et al., 2000) . Sorokin and Reed have reported a switch of Crk from p130Cas to which it is initially bound onto the IRS-1 protein in response to insulin stimulation (Sorokin and Reed, 1998) . If and how this aects the transmission of insulin signals to Crk eector molecules remains to be clari®ed. A similar switch from p130Cas to another large docking protein, Gab1, has been reported for cells transformed by the Tpr-Met oncoprotein (Lamorte et al., 2000) .
Gab proteins
In addition to the IRS family, a group of similarly structured proteins which may be considered`distant cousins' of IRS proteins have been identi®ed. These Gab proteins also possess one N-terminal PH domain and multiple SH2 domain docking sites but lack a PTB domain Schlessinger, 2000) . So far, only the sequences of Gab1 and Gab2 have been published (Holgado-Madruga et al., 1996; Gu et al., 1998; Nishida et al., 1999; Zhao et al., 1999) but Gab3 was already cloned (LR Rohrschneider, personal communication; Miyakawa et al., 2001) and at least one additional Gab protein seems to exist. Human and mouse Gab3 proteins do not contain Y-x-x-P motifs conserved in both species (there is one Y-x-x-P motif in mouse which is not present in human Gab3), so it seems unlikely that Gab3 is a direct binder of the Crk and CRKL SH2 domains. Gab proteins have been shown to form complexes with Crk family adaptors in various cell types.
Gab1 contains six potential Crk/CRKL SH2 domain binding sites (see Sakkab et al., 2000) . Upon HGFstimulation of epithelial cells (HEK293; HeLa etc.), Crk and CRKL form complexes with Gab1 (GarciaGuzman et al., 1999; Sakkab et al., 2000 Sakkab et al., , 2001  reviewed in Furge et al., 2000) . Deletion of the 6(Yx-x-P)-region in Gab1 abolishes binding of CRKL. Stimulation of epithelial cells with HGF leads to activation of the GTPase Rap1 and c-Jun N-terminal kinases (JNKs). Both of these HGF-activated pathways depend on complexes built by Crk/CRKL. The functional outcome of these signals include the upregulation of certain matrix metalloproteinases and reduced cell adhesion (Garcia-Guzman et al., 1999; Sakkab et al., 2001) .
The phenotype of mice with a disrupted gab1 gene indicates that it has developmental functions in organs like placenta, heart and skin (Itoh et al., 2000) . This pathology is similar to that of mice with de®ciencies in growth factors like HGF, PDGF or EGF. Gab1-de®cient mice also have a reduced liver size and various cell migration defects, resulting in disturbed muscle development and reminiscent of the defects observed in c-met (7/7) mice . Since Crk and CRKL are also implicated in the regulation of cell migration events and c-Met signalling, it should be interesting to cross and analyse heterozygous and homozygous animals of the recently generated crklknockout (Guris et al., 2001 ) with c-Met and Gab1 (+/7)-or (7/7)-animals to look for phenotype enhancement.
Gab2, initially designated p97, is prominently expressed in haematopoietic cells. It forms complexes with CRKL in interleukin-2 (IL-2)-stimulated T-cells (Gesbert et al., 1998b) . In erythroid cells stimulated with Epo, Gab1 and Gab2 are also heavily tyrosinephosphorylated (Wickrema et al., 1999) and recruited to the Epo receptor-connected signalling complex. CRKL is also recruited into this complex (reviewed in Wojchowski et al., 1999) . The situation is therefore reminiscent of c-Cbl, which also binds to Crk when it is tyrosine phosphorylated after Epo-stimulation of cells Chin et al., 1997) . Again the functional consequences of Gab ± Crk/CRKL complexes in haematopietic cells are not well understood yet. One protein which is recruited to the activated Epo and T-cell receptors is HPK1 (Nagata et al., 1999; Hehner et al., 2000; Liou et al., 2000; Ling et al., 2001 ), a serine/threonine kinase of the germinal centre kinase (GCK) subfamily, which in turn belong to the PAK kinase superfamily (Sells and Cherno, 1997) . HPK1 binds to the SH3(1) domains of Crk and CRKL via a proline-rich motif in its noncatalytic region and can for example activate JNK (Oehrl et al., 1998; and others) . The downstream signals generated by Crk/CRKL ± HPK1 complexes remain, however, at present largely elusive.
So far many experiments studying the function of Epo have been done with erythroid cell lines. This sometimes leads to con¯icting results, depending on the cell line used. To gain further insight into the possible biological roles of complexes between Crk and Gab family proteins, it should be useful to analyse primary haematopoietic cells, even if it is more demanding to study crucial enzymatic activities like GTPases, kinases and phosphatases in primary isolates.
STAT5
Epo stimulation of erythroid cells also leads to the activation of the STAT5 transcription factors (for reviews see Wojchowski et al., 1999; Coer et al., 2000; Smithgall et al., 2000) . Besides the well-known STAT dimers, heterodimers of STAT5 and CRKL were reported upon Epo-treatment of cells in several studies, and also with other cell stimuli Ota et al., 1998; Ozaki et al., 1998; and others) . Whether STAT5 ± CRKL complexes are crucial for signal transmission of Epo in vivo is still an open question. STAT5 exists in two forms, STAT5a and STAT5b, which are products of highly related but distinct genes. STAT5a,b doublede®cient mice have a normal adult haematopoiesis but appear to have defects during their embryonic haematopoiesis, which can apparently be compensated later in development under laboratory conditions (Socolovsky et al., 1999) , although this could lead to a signi®cantly lower viability in free nature. If STAT5 ± CRKL complexes occur during embryonic development and whether they are then part of a functionally important signalling cascade remains to be studied. It is also not known, though tempting to speculate, whether a CRKL ± STAT5 heterodimer formed via their SH2 domains would allow the CRKL SH3 domains to bring additional enzymes, for example kinases like c-Abl or HPK1 into the nucleus. c-Abl is well known to have nuclear functions (Shaul, 2000; Wang, 2000) and both HPK1 and c-Abl can phosphorylate c-Jun in vitro (Barila et al., 2000; EK Schmidt and SM Feller, unpublished data) . Furthermore, c-Abl and HPK1 were found to bind to each other upon experimentally-induced DNA-damage (Ito et al., 2001) . Complexes of STAT5, CRKL and kinase(s) binding to transcription-regulating elements could certainly open up interesting new ways of controlling STAT5-dependent transcription events.
SHIP and DOKs
DOK (downstream of tyrosine kinases) proteins are generally characterized by an N-terminal PH domain followed by a PTB domain, which both show about 50 ± 60% homology between DOK family members, and then a more diverse C-terminal region with multiple SH2 domain docking sites. Dok proteins are known to bind to p120RasGap, the tyrosine kinases Abl, Lyn and Tec and the inositol 5-phosphatase SHIP (Carpino et al., 1997; Yamanashi and Baltimore, 1997; Brauweiler et al., 2000; van Dijk et al., 2000) . p62dok (DOK1), the ®rst family member to be cloned (Carpino et al., 1997; Yamanashi and Baltimore, 1997 ) is heavily tyrosine-phosphorylated in Bcr ± Abl-and v-Abl-expressing haematopoietic cells. Mouse and human p62dok both have 6 Y-x-x-P motifs. In p56dok-2 (DOK-R, DOK2) four Y-x-x-P motifs are conserved between the human and mouse proteins (Di Cristofano et al., 1998; Jones and Dumont, 1998). DOK-3, however, although otherwise similar in structure, lacks Y-x-x-P motifs (Lemay et al., 2000) .
Crk has been reported to bind constitutively to Dok-R, presumably via its proline-rich tail (Jones and Dumont, 1998) . On the other hand, tyrosine-phosphorylated p62dok in Bcr ± Abl kinase-expressing cells binds to CRKL via its SH2 domain (Bhat et al., 1998) . SHIP1 (for review on SHIPs see Rohrschneider et al., 2000) can apparently also bind to both, CRKL and DOK1 (Sattler et al., 2001) . The interaction of SHIP1 and DOK1 occurs via the DOK PTB domain with Y917 and Y1020 of SHIP1. The binding site of the CRKL SH2 domain to SHIP has yet to be mapped but candidate Y-x-x-P motifs are present in SHIP1. In the same publication, a constitutive association of PI3 kinase with CRKL, presumed to occur via the CRKL SH3 domains, was also documented. This brings up the possibility that CRKL could serve in certain situations to stabilize a SHIP ± PI3 kinase complex and may allow cross-talk and concerted action of these two phosphoinositide-modifying enzymes. Additional stability for such a ternary complex could come for example from a PI3 kinase p85 binding motif present in SHIP1 (Gupta et al., 1999; Lucas and Rohrschneider, 1999) .
ZAP-70
ZAP-70 (T cell receptor zeta-chain associated protein of 70 kDa) is a cytoplasmic tyrosine kinase implicated in T-cell receptor function (Chan et al., 1992 , reviewed in Chu et al., 1998 . It was originally identi®ed in Jurkat T-cells and contains two SH2 domain which precede the catalytic domain. One study has reported that in T-cell receptor-stimulated Jurkat cells, Crk coimmunoprecipitates with active ZAP-70 kinase (Gelkop and Isakov, 1999) . A direct binding of the CrkSH2 domain is suspected, presumably to one of the three ZAP-70 Y-x-x-P motifs (Y221, Y315, Y319). ZAP-70 phosphorylation on these sites probably depends on the Src family kinase Lck or a similar kinase. Functional outcomes of the Zap70-Crk interaction could include the recruitment of substrates like Cbl or Cbl-b to ZAP-70 via the Crk SH3 domain(s) (Elly et al., 1999) or a protection of ZAP-70 from dephosphorylation by PTPases.
C3G
C3G was the ®rst Crk SH3 domain binding protein identi®ed (Knudsen et al., 1994; Tanaka et al., 1994) . The binding sites of C3G for Crk and CRKL have been mapped to the already mentioned P-x-x-P-x-K motifs in the centre of the protein . Both Crk and CRKL exist in constitutive complexes with C3G in many cell types, but a regulation of these complexes has also been reported in response to insulin receptor activation, integrin stimulation and other stimuli (Okada et al., 1997 (Okada et al., , 1998 Buensuceso and O'Toole, 2000) . The situation is somewhat similar to the dissociation of the Rasactivating Grb2 ± SoS complex. The dierence is that the exchange factor SoS is phosphorylated for example by MAP kinases or RSK-2 leading to dissociation from Grb2, while the crucial phosphorylation event required for c-Crk II ± C3G dissociation after insulin-stimulation of Chinese hamster ovary cells seems to be c-Crk II (Y221)-phosphorylation (Okada et al., 1998) which allows the intramolecular binding of the c-Crk II SH2 domain to pY221 (Feller et al., 1994b; Rosen et al., 1995) . C3G can also become tyrosine-phosphorylated, but this phosphorylation is thought to upregulate its activity rather than to lead to dissociation from Crk (Ichiba et al., 1999) . It is clear that c-Crk I ± C3G complexes cannot be regulated by this mechanism, since the truncated c-Crk I protein ends before the Y221 residue. Possible speci®c functions of c-Crk I ± C3G complexes or other c-Crk I complexes have not yet been analysed in any detail.
C3G appears usually as multiple bands in Western blots and several splice forms exist (Knudsen et al., 1994; Shivakrupa and Swarup, 1999) . Their functional dierences are not yet studied. It is, however, now well established that C3G is a guanine nucleotide releasing protein which removes GDP from the small GTPase Rap1 allowing its spontaneous reloading with GTP (Gotoh et al., 1995; van den Berghe et al., 1997) which leads to the recruitment of eector molecules like BRaf and active signalling. Binding of the Crk/CRKL SH2 domains to newly generated target sites on activated receptors and their substrate proteins leads to a redistribution of C3G within the cell, presumably to sites where Rap1 is located. When C3G comes into the vicinity of activated tyrosine kinases, phosphorylation of the regulatory tyrosine residue (Y504) could occur, although C3G ± Y504 phosphorylation was so far only observed in certain oncogene-transformed cells with hyperactive tyrosine kinases (Ichiba et al., 1999) . Integrin stimulation-dependent tyrosine phosphorylation of C3G was also reported (de Jong et al., 1998) but the exact site has not been mapped so far.
For several years, C3G was the only identi®ed activator of Rap1 but now a considerable and still growing number of Rap1-activating proteins which do not interact with Crk family adaptors is known (reviewed in Zwartkruis and Bos, 1999; see also Dodelet et al., 1999; Clyde-Smith et al., 2000; Gotoh et al., 2000; Rebhun et al., 2000; Yamashita et al., 2000 and others) . However, inducible Crk/CRKL complex formation and activation of Rap1 has been observed in dierent cell types and with several dierent stimuli (Ichiba et al., 1997; Garcia-Guzman et al., 1999; Alsayed et al., 2000; Du et al., 2000; Posern et al., 2000; Sakkab et al., 2000 Sakkab et al., , 2001 Xing et al., 2000) . In some of these cases, for example in HGF-stimulated human embryonic kidney epithelial cells and Swiss 3T3 mouse ®broblasts stimulated with bombesin, it was clearly shown that Rap1 activation is dependent on Crk family adaptors Sakkab et al., 2000 Sakkab et al., , 2001 . Other Ras-superfamily GTPases like RRas and TC21(R-Ras2) also appear to be targets of C3G (Gotoh et al., 1997; Ohba et al., 2000) although the evidence is still less striking.
The downstream targets of GTP-loaded Rap1 are in most cases not well characterized, with one exception: the cytoplasmic kinase B-Raf has been implicated as a Rap1-target in many studies (Ohtsuka et al., 1996; Vossler et al., 1997; York et al., 1998; Dugan et al., 1999; Czyzyk et al., 2000; Grewal et al., 2000; Schmitt and Stork, 2000; and others) . This leads to activation of the MAPK/Erk kinases and subsequent activation of the transcription factor Elk-1. However, many of these studies report Crk/CRKL-independent activation of Rap1 and the B-Raf protein is not expressed in many cell types where Crk ± C3G ± Rap1 signal signalling activity has been detected. Other possible candidates need to be analysed in much more detail, for example the Ral ± GDS-like proteins RGL and RGL-2 (Ikeda et al., 1995; Peterson et al., 1996) and the Ral ± GDS-like factor (Rlf) (Wolthuis et al., 1996) , but also more recently found candidates like the cell junctional multidomain protein AF-6 (Boettner et al., 2000) and RGS14, a member of the`regulator of Gprotein signalling' family (Traver et al., 2000) . Activation of the`stress kinase' JNK by Crk and C3G (Tanaka et al., 1997; Dol® et al., 1998; Tanaka and Hanafusa, 1998; Zhu et al., 1998) has also been reported, but how this exactly occurs remains to be de®ned although a recent report suggests that R-Ras rather than Rap1 may be responsible for this.
Besides its catalytic GNRP (syn. GEF) domain at the C-terminus and a Ras-exchanger motif (REM; Guerrero et al., 1998) , C3G probably has presumably other functionally important domains (Guerrero et al., 1998) which are not well characterized yet. For example, C3G binds to the large docking protein p130Cas which also interacts with AND-34, another already mentioned Rap1 activator (Kirsch et al., 1998) but it is not clear whether ternary C3G ± p130Cas ± AND-34 complexes can occur.
DOCK180
DOCK180, a prominent 180 kDa Crk SH3(1) domain binding protein initially detected in`Far Western' overlay blots was cloned by Miki Matsuda's laboratory (Hasegawa et al., 1996) . Homologous proteins were also found in C. elegans (CED-5; Wu and Horvitz, 1998) and Drosophila (MBC; Erickson et al., 1997) , two organisms that have provided important clues for Crk signalling functions in living organisms.
Importantly, it was quickly found that DOCK180 binds and activates the GTPase Rac but not the related GTPase Cdc42 Nolan et al., 1998) making it very clear that Crk eector proteins are important regulators of multiple Ras-family GTPases. Rac is known to play a key role in controlling actin dynamics, integrin-mediated cell adhesion and cell shape changes, but also in the engulfment of dead cell bodies (Giancotti, 1997; Cheresh et al., 1999; . Very recent ®ndings are the recruitment of DOCK180 to membranes by binding of its C-terminus to phosphatidylinositol (3,4,5) trisphosphate (PIP 3 ) and the observation that increased expression of PI3 kinase translocates DOCK180 to the membrane (Kobayashi et al., 2001 ). This opens up interesting new possibilities for a crosstalk of PI3 kinase with DOCK180-dependent signals to Rac. According to other very recent results, DOCK180 also binds with its C-terminal region to the second and third SH3 domain of the Nck-like adaptor Grb4 (Nck-2, Nck-b, Nckb; Tu et al., 2001) but functional consequences of this interaction are not known. DOCK2, a DOCK180-relative prominently expressed in haematopoietic cells and also known to activate Rac (Nishihara et al., 1999) , has no obvious Crk binding motifs and no Crk binding was detected.
The Abl family c-Abl and Arg (Abl related gene) are large nonreceptor-type tyrosine kinases which exist in several spliceforms and appear in multiple locations within cells. According to the results obtained with knockout mice and other studies, c-Abl and Arg transmit key signals during the embryogenic development of nervous system (Koleske et al., 1998; Liebl et al., 2000) and bone formation (Li et al., 2000a) . Many of the key functions of Abl family kinases may thus be already completed in adult animals or individuals. Indirect support for this hypothesis comes from the results of clinical trials with STI 571 (CGP57148B, Glivec), an Abl and Arg kinase inhibitor compound which shows promising early results as a therapeutic agent for Bcr ± Abl-driven chronic myelogenous leukaemia (CML) (Schindler et al., 2000; Druker and Lydon, 2000; Okuda et al., 2001) . STl571 has, maybe suprisingly, relatively little severe side eects in CML patients, arguing for a lack of key pathways which are primarily controlled through Abl family kinases in adults. On the other hand, nuclear c-Abl pools have been implicated in the control of DNA-damage sensing by ATM (Baskaran et al., 1997; Shafman et al., 1997) . Adverse STl571-eects on nuclear c-Abl functions may only become apparent upon long-term treatment of patients.
An in vitro interaction of c-Abl and Arg with c-Crk is known for quite a few years (Feller et al., 1994b; Ren et al., 1994) , but only recently has c-Abl been linked to Crk signalling in cell culture model systems (Escalante et al., 2000; Yano et al., 2000a; Kain and Klemke, 2001) . Possible functions of Crk ± Abl interactions include the negative regulation of ®broblast migration and dierentiation induction by nerve growth factor (NGF). While this manuscript was being written, Kain and Klemke reported that c-Abl/Arg double-de®cient mouse ®broblasts display an increased Crk/Cas signalling and an enhanced cell motiliy (Kain and Klemke, 2001) .
Although c-Abl plays an important role in controlling genomic integrity in the cell nucleus, there is at present little evidence to strongly support a nuclear role for Crk family adaptors in mammals, despite the already mentioned STAT5 ± CRKL complexes and results from biochemical experiments with Xenopus oocyte extracts which found co-immunoprecipitation of Crk with the cell cycle regulator XWee1 . Given the defects found in the Abl/Arg-`knockouts' but also in CRKL-de®cient mice (Guris et al., 2001) , embryonic development seems to be the best place to ®nd additional clues for major roles of Crk/ CRKL ± c-Abl/Arg complexes in intracellular signal transmission.
The oncogenic v-Crk protein co-precipitates with cAbl from chicken embryo ®broblast lysates which has led to the suggestion that c-Abl (and Arg) could be a major kinase relevant for v-Crk transformation (Feller et al., 1994b ) but this hypothesis is questioned by other ®ndings which suggest the Src family kinase Fyn to be more important for tyrosine phosphorylation of p130Cas in v-Crk-expressing mouse ®broblasts . Nevertheless, v-Crk and c-Crk were just shown to trans-activate the c-Abl kinase (Shishido et al., 2001 ) in 293T cells. With the availability of the Abl and Arg kinase-inhibiting molecule STI571 (which also blocks the tryosine kinases PDGF receptor and c-Kit but not Src family kinases) or similar compounds, it may now be possible to get some new answers in search for the kinase primarily responsible for the massive hyperphosphorylation of tyrosyl residues in p130Cas, paxillin and other proteins of v-Crk-transformed chicken embryo ®broblasts and chicken tumours. Abl and Arg double-de®cient mouse ®bro-blasts may also be a useful tool for such studies.
Human leukaemic Abl kinases
Bcr ± Abl and Tel ± Abl, the leukaemia-inducing counterparts of the c-Abl kinase, arise from chromosomal translocations and are well known to phosphorylate CRKL and c-Crk II (Voss et al., 2000, and references therein) . The Bcr ± Abl fusion protein is found in more than 95% of human adult CMLs. This constitutively active kinase has been the focus of a great number of studies which showed that numerous cellular signalling pathways are aected by its expression (reviewed in Sattler and Salgia, 1998; Faderl et al., 1999; Sawyers, 1999; Voss et al., 2001) . Functional consequences of the aberrantly high tyrosine kinase activity permanently maintained by Bcr ± Abl and Tel ± Abl include reduced cell adhesion, increased proliferation and protection against cell death.
The human gene encoding the CRKL protein was found due to its localization near the bcr locus (breakpoint cluster region) on chromosome 22 (band q11) (ten Hoeve et al., 1993) . Furthermore, CRKL forms stable complexes with Bcr ± Abl (ten Hoeve et al., 1994b) and is a prominent tyrosine phosphorylated protein in neutrophils from CML patients (Oda et al., 1994; ten Hoeve et al., 1994a; Nichols et al., 1994) . The direct interaction of CRKL and Bcr ± Abl is, at least in part, mediated by a proline-rich region in the Cterminal tail of the Abl kinase which is localized near the nuclear localization signal of the Abl sequence and binds to the ®rst SH3 domain of CRKL. The inhibition of complexes mediated by the CRKLSH3(1) domain in CML cell lines and primary isolates from patient cells can inhibit the proliferation of these cells . By contrast, enhanced expression of CRKL has just the opposite eect: mice transgenic for the p190 Bcr ± Abl protein developed leukaemia more rapidly when CRKL was overexpressed four-to sixfold (Hemmeryckx et al., 2001 ).
HPK1 and KHS
Based on homology comparisons, the already mentioned haematopoietic progenitor kinase 1 (Hu et al., 1996; Kiefer et al., 1996) and its relative KHS (kinase homologous to SPS1/STE20; also cloned as germinal centre kinase related kinase [GCKR]; Shi and Kehrl, 1997; Tung and Blenis, 1997) are members of the still growing superfamily of PAK-related serine/threonine kinases. They lack the CRIB domain found in some other family members which is known to mediate binding to the GTPase Rac. Instead, the N-terminal kinase domain of HPK1 (amino acids 17 ± 274) and KHS is followed by a large C-terminal part which has multiple putative SH3 domain binding sites (reviewed in Kyriakis, 1999) . HPK1 and KHS both bind to the ®rst SH3 domain of Crk and CRKL (Oehrl et al., 1998; Ling et al., 1999 Ling et al., , 2001 Shi et al., 2000) and may thus be yet another (C3G-independent) link from Crk/ CRKL to JNK activation.
Binding of HPK1 to the Abl SH3 domain in a yeasttwo-hybrid screen was already described a few years ago (Kiefer et al., 1996) . A brand new study now reports that HPK1 and c-Abl do indeed bind to each other in response to genotoxic stress induced by chemical or radiation treatment of Jurkat cells (Ito et al., 2001) . If and how Crk family adaptors are involved here remains to be investigated.
HPK1 and KHS also have in their noncatalytic parts (amino acids 500 ± 805 of HPK1) a citron homology region (CNH). It is named after the Rac and Rho binding protein citron (Madaule et al., 1995) which appears due to dierential splicing also as citron kinase and regulates neuronal cytokinesis (Madaule et al., 1998 (Madaule et al., , 2000 Di Cunto et al., 2000) . The function of this CNH region, which is sometimes also called CMG (Citron ± MRCK ± Gek) domain and occurs in over 60 proteins of diverse origin, remains to be clari®ed.
HPK1 is expressed exclusively in haematopoietic cells while KHS was also found in some nonhaematopoetic cells, for example epithelial cells and ®broblasts. Certain cell lines, which require Epo for proliferation (FD ± Epo) or dierentiation (SKT6) were shown to depend on HPK1 for their Epo-response (Nagata et al., 1999) but other Epo-dependent cells (like UT-7 and TF-1) apparently do not show this eect. Therefore, these results should be followed up by performing experiments with primary cell isolates. HPK1 activity is also induced by T-cell and B-cell receptor engagement (Liou et al., 2000) and downregulates Erk2 and AP-1 activity in T cells. It may thus function as a negative regulator of the TCR response. The protein complexes assembled in order to activate HPK1 appears to involve multiple adaptor proteins like LAT, SLP-76, Blnk, Grb2 and GRAP, but also several tyrosine kinases (Src, Syk, ZAP-70). Interestingly, one study which looked at TCR-stimulation in Jurkat T cells just found tyrosine phosphorylation of HPK1 and inducible binding of HPK1 to c-Crk, but also a constitutive complex of HPK1 and CRKL . Further details of these interactions and possible functional consequences are currently unclear.
The HPK1 gene locus has been disrupted by gene targeting several years ago but apparently no phenotype compared to wildtype mice was observable and the results were not published. Whether detailed analyses of HPK1(7/7) mice can ®nally unravel a rather subtle phenotype or whether HPK1 function can be fully compensated by other kinases of this relatively large kinase family remains an open question.
PI3 kinase
After the early ®nding of Fukui et al. (1989) that v-Crk associates with phosphatidylinositol kinase activity, only few studies investigated a functional connection between Crk and phosphatidylinositol kinases. The p85 alpha and beta subunits of PI3 kinase contain P-x-x-Px-K motifs which could serve as Crk/CRKL SH3(1) domain binding sites (reviewed in Feller et al., 1998) but there are only few reports suggesting a stable interaction (Sattler et al., 1997 (Sattler et al., , 2001 Gesbert et al., 1998a) . Ternary complexes which do not require a single high anity interaction but rely on multiple intermediate to low anity binding sites are of course also a possibility; the SH2 domains of the p85 subunit bind with high anity to pY-(M)-x-M motifs of Cbl-, Gab-and IRS-family proteins which allow binding of Crk/CRKL via their pY-x-x-P motifs. This could allow Crk/CRKL to bind to p85 with their SH3(1) domains, thereby possibly modulating complex stability or enzyme function. Along these lines, a recent study shows that the viral oncoprotein v-Crk activates PI3 kinase (Akagi et al., 2000) . This leads to activation of the kinase c-AKT (PKB) but does apparently not eect the JNK or MAP kinase pathways. Inhibition of PI3 kinase activity with the inhibitor compound LY294002 suppressed v-Crk-induced cell transformation.
Regulation of the c-Crk II protein conformation by tyrosine phosphorylation
In the search for Crk interacting proteins, it was found early on that c-Crk II binds to the c-Abl kinase. c-Crk II is also phosphorylated by c-Abl on tyrosine 221, a residue absent in the shorter c-Crk I protein (Feller et al., 1994b) . The c-Crk II Y221 sequence motif is conserved in the CRKL protein and the corresponding tyrosine (Y207) is the major tyrosine phosphorylation site of CRKL in Bcr ± Abl-expressing cells (de Jong et al., 1997). Crk Y221 and CRKL Y207 conform to the Y-x-x-P motif found as preferred Crk/CRKL SH2 domain binding motif by Songyang et al. (1993) . Moreover, c-Crk II was found in non-complexed, tyrosine-phosphorylated form in HeLa cell protein extracts. The same extracts contained proteins which bound eciently to bacterially expressed, not tyrosylphosphorylated c-Crk II protein. These results led to the hypothesis that the phosphorylated Y221 of c-Crk II can bind to its own SH2 domain, presumably in an intramolecular fashion, and that this somehow blocks the SH3(1) domain of c-Crk II from binding to other proteins (Feller et al., 1994b) . The model is similar to the regulatory folding model long proposed for Src family kinases and ®nally con®rmed for c-Src and Hck by crystallographic and functional analyses Sicheri et al., 1997; Xu et al., 1997) .
Based on the`Crk folding hypothesis', an ultrastructural study using NMR was carried out which further supported this idea but fell short of providing further mechanistic details (Rosen et al., 1995) . Subsequently, several reports accumulated evidence using cell culture models which support this hypothesis, initially based only on biochemical in vitro data. In response to EGF, insulin or NGF-treatment of certain cells, a phosphorylation of c-Crk II on Y221 which is followed by dissociation of complexes mediated by the SH3(1) domain of c-Crk II has been repeatedly found (Beitner-Johnson and LeRoith, 1995; Okada et al., 1997 Okada et al., , 1998 Koval et al., 1998a; Hashimoto et al., 1998; Nakashima et al., 1999; Escalante et al., 2000; Kain and Klemke, 2001 ). These events are probably cell type-speci®c and can be only analysed on a case by case basis. Moreover, dierences between c-Crk II and CRKL have been found. For example Butler et al. (1997) report upon IGF-1 stimulation of cells an increase in c-Crk II ± paxillin complexes but a decrease in CRKL ± paxillin complexes. Taken together, the current data show that two very dierent outcomes with respect to Crk signalling can occur after the activation of intracellular tyrosine kinases. On one hand, tyrosine phosphorylation of Y-x-x-P-motif-containing proteins generates CrkSH2 domain binding sites, relocating CrkSH3(1) domain-interacting enzymes and leading to the active transmission of signals. On the other hand, tyrosine phosphorylation of c-Crk II on Y221 somehow leads to the dissociation of CrkSH3(1) bound proteins and downregulates Crk signals. In principle, both of these events can take place in temporal succession, ®rst an active signal and subsequently downregulation of the signal by c-Crk II folding, resulting in a transient activation peak followed by desensitization of the Crk signalling pathway. Since Rap1 and Ras can compete for eector proteins like B-Raf, switching-o Crk signals may allow the Grb2 ± Sos ± Ras ± B-Raf pathway to signal more eciently. The desensitization period could, however, also be avoided if the`folded-up' c-Crk II is rapidly reopened and new complexes are established, allowing for example a rapid switch from one binding partner to the next.
There are still many open questions regarding the regulation of Crk signalling by folding: Can Y221-phosphorylation lead to intramolecular CrkSH2 domain interactions even if the SH2 domain is initially bound to other proteins like p130Cas or Gab1? How does Y221-phosphorylation lead to dissociation of CrkSH3(1) binding proteins? Are there other tyrosines also phosphorylated and functionally important for Crk and CRKL folding? What are the dierences between c-Crk II and CRKL with respect to folding regulation by Y221 and Y207, respectively? Is thè folded-up' Crk protein further utilised in vivo by reactivation through a tyrosine phosphatase? How is it decided which of the several SH3(1) domain binding proteins expressed in cells is actually recruited to form an active`pre-complex'? Some new insight should come from a detailed ultrastructural analysis of Y221-phosphorylated c-Crk II by X-ray crystallography and/or NMR, followed by mutational analyses of other crucial Crk residues thus identi®ed.
Many of the studies which have looked at Crk folding in living cells used cell lines transfected to express certain receptors in high numbers. The results may therefore not re¯ect the true behaviour of the Crk protein in vivo, making it desirable to also look at primary cells which should re¯ect more closely the in vivo situation. When feasible, such experiments with cultured cells should be followed by`knock in' studies, for example expression of a c-Crk II Y221F-or CRKLY207F-mutant protein into mice with a disruption of the corresponding gene.
Crk functions in Drosophila melanogaster
While most of the Crk/CRKL-related studies have been done with mammalian and avian cells, it is now known that Crk does not only have functions in amphibians but proteins homologous to Crk and its eector proteins (C3G, DOCK180, c-Abl) are indeed conserved and functionally important throughout very dierent higher eukaryotes. In the fruit¯y, genes for Crk (Galletta et al., 1999) , DC3G (Ishimaru et al., 1999) and the DOCK180-homologue MBC (myoblast city; Erickson et al., 1997; Nolan et al., 1998) were cloned and functionally characterized. MBC is important for myoblast fusion, dorsal closure and neural development, phenotypes which may be linked at least in part to a role of MBC in the migration of speci®c cells. MBC is presumed to signal through the Drosophila GTPase Rac1, but does not seem to be crucial for the activation of JNK, although JNK is one target of Rac in mammalian cells. DC3G appears to play a role in the regulation of cell fates and proliferation since a membrane-tagged full-length DC3G, which is believed to function as a constitutively active form of DC3G, leads to phenotypes mimicking an overactivation of the Ras1 ± MAPK pathway. A truncated (dominant negative) version, lacking the catalytic domain, leads to morphogenetic defects (Ishimaru et al., 1999) . Reduc-tion of the gene doses of Rap1 or Ras diminished the eects induced by expression of`overactivated' DC3G. Another study, which also analysed Rap1, found that it is critical for morphogenesis of the¯y eye, the ovary and the embryo, and that Rap1 mutations disrupt cell migration and normal cell shapes. They found no results to implicate Rap1 in cell proliferation or cellfate speci®cation (Asha et al., 1999) .
Crk functions in Caenorhabditis elegans
Several proteins homologous to Crk and its downstream signalling partners have been identi®ed as the genes behind a number of cell engulfment defect (`ced') mutants (reviewed in Blelloch et al., 1999; Liu and Hengartner, 1999; May, 2001) . It is now clear that corresponding signalling cascades comprised of CED-2 (c-Crk II) -CED-5 (DOCK180) and CED-10 (Rac) exist in C. elegans and mammals. Moreover, CED-12, which is not yet de®ned in its molecular nature, has been implicated in the C. elegans pathway by genetic analyses (Chung et al., 2000) .
A key ®nding that illuminated the molecular nature of a cell engulfment signalling cascade and also migration regulation of two gonadal tip cells in C. elegans is described in the work of Wu and Horvitz (1998) . In this paper, CED-5 was cloned and found to be highly homologous to the Rac-activating Crk SH3 domain binder DOCK180. Later on it was shown in the same laboratory that CED-2 (Crk) and CED-10 (Rac) do in fact control phagocytosis and cell migration (Reddien and Horvitz, 2000) . In mammals, phagocytosis is prominently controlled by speci®c integrins expressed on phagocytosing cells. In C. elegans, CED-1 was just recently cloned and shown to be a receptor related to the mammalian SREC protein (scavenger receptor from endothelial cells; Zhou et al., 2001) . It is functionally linked to CED-7 an ABC transporter protein. Genetic evidence suggests that there are two functionally distinct groups of ced genes which regulate cell engulfment, the ®rst comprised of ced-1, ced-6 and ced-7 and the second encompassing the genes ced-2, ced-5, ced-10 and ced-12.
The upstream molecules which activate the CED-2, CED-5 and CED-10 pathway remain unknown. However, in recent phagocytosis studies with mammalian cells ± which were inspired by the ®ndings in C. elegans ± it was documented that at least the intracellular portion of the cell engulfment signalling cascade is very similar to the nematodal signalling pathway (Albert et al., 2000; Savill and Fadok, 2000; ToselloTrampont et al., 2001) .
Crk in mammals
A very large number of stimuli aect Crk adaptors in mammalian cells. In many of the cases it is not well understood if c-Crk and/or CRKL are merely`innocent bystanders' or if they are indeed crucial players regulating the elicitation of biological responses. An (incomplete) list of stimuli reported to aect Crk family adaptors is given in Table 1 . Of these just two examples will be discussed.
Cell migration
Directional movement of speci®c cells is crucial during embryo development in higher eukaryotes but also postnatally throughout the life of a complex organism. Constant remodelling of tissues, replenishment of peripheral blood cells from the bone marrow, maturation of B-cells and T-cells, function of dendritic cells and other immune defence cells, wound repair and in¯ammatory reactions are just a few of the migrationdependent events in mammals and other complex metazoa which are needed to maintain functional integrity and to fend o pathogens. Diseases caused by certain bacterial infections, tumour growth and the spreading of tumour metastases can also only occur because abnormal migratory events of cells are induced. The many dierent migration events are for example regulated by gradients of motility inducing factors and cell ± cell contacts but also by cell interactions with extracellular matrix (ECM) proteins. This creates a versatile regulation system for the delicate signalling networks which ®ne tune the responses of the huge numbers of cells permanently on the move.
Since v-Crk is a potent oncoprotein in chicken, it could be expected from the beginning that v-Crk also aects cell signalling events which regulate cell migration. Nevertheless, only relatively few studies have been conducted which begin to address the details of v-Crk induced migration processes (Liu et al., 2000 and references therein) . Possible functions of cellular Crk and CRKL proteins in cell migration have, on the other hand, received more attention and there is now good evidence that c-Crk and CRKL are important regulators of physiological cell migration in mammalian cells (reviewed in Hanks and Polte, 1997; Stupack et al., 2000) . Migration-regulating Crk/CRKL signals are generated downstream of migration-inducing factors like HGF and bombesin and upon activation of integrins. Integrins are a large family of cell surface receptors which make contacts with other cells but also with ECM proteins like ®bronectin and collagens (Giancotti and Ruoslahti, 1999; O'Neill et al., 2000) . Stimulation of cells with bombesin or integrin activation leads to tyrosine phosphorylation of the p130Cas protein (Vuori et al., 1996; Casamassima and Rozengurt, 1997) allowing the SH2 domains of Crk and other signal transducers to dock and leading to the recruitment of multiple enzymes. Cas ± Crk coupling appears to be a`molecular switch' which induces cell migration and may enhance invasivity of some tumour cells although other signalling pathways which lead to the activation of MAP kinase and myosin light chain kinase (MLCK) are equally important in controlling cell motion (Klemke et al., 1998; Cheresh et al., 1999; Cho and Klemke, 2000) . The current data support a model for ECM ± integrin downstream signalling through a FAK/Src ± p130Cas ± Crk/CRKL ± DOCK180 ± Rac cascade which aects actin cytoskeleton changes and also cell survival. In addition, other CrkSH3(1) domain binding proteins could play a role in the control of cell motion, for example c-Abl which seems to function as a negative regulatory protein (Kain and Klemke, 2001) .
HGF (syn.`scatter factor') triggers in epithelial cells the formation of a dierentially composed signalling complex consisting of c-Met, Gab1 and Crk/CRKL. This leads to the activation of the GTPases Rap1 and Rac (Garcia-Guzman et al., 1999; Sakkab et al., 2000 Sakkab et al., , 2001 ; reviewed in Furge et al., 2000) and results in the dispersion of epithelial cell clusters (scattering). Since most human tumours are of epithelial origin and disruption of intact epithelial layers is clearly a prerequisite for tumour invasion/metastasis, it seems worthwhile to investigate in the future possible roles for c-Crk and CRKL in mediating the invasiveness of certain tumour cells.
Nerve growth factor
Whether NGF relies on Crk family adaptors for signal transmission in animals is currently not certain. Forced expression or microinjection of v-Crk or cCrk proteins has signi®cant eects on factor responsiveness and development of the neuronal phenotype in NGF-sensitive cells (Tanaka et al., 1993; Hempstead et al., 1994; Matsuda et al., 1994) , but whether this re¯ects a natural role for cellular Crk proteins in NGF-signalling remains to be proven. Most studies in this context have so far been conducted with the PC12 rat pheochromocytoma cell line model system. These cells respond by an extensive outgrowth of neurite-like structures in the continuous presence of NGF. York et al. (1998) proposed a model of Rap1 activation by C3G that depends on c-Crk/CRKL and leads to sustained activation of MAP kinase via complex formation of GTP-loaded Rap1 and B-Raf. However, this publication relied much on transfected PC12 cells. Several other research groups have failed to detect Rap1-activation after NGF-treatment of PC12 cells before and after this report, possibly due to clonal drift and resulting variations between the PC12 cells used in the dierent laboratories. Overexpression of the tyrosine kinase GTK (also called BSK, IYK, FRK or RAK) or other proteins like Shb in PC12 cells apparently favours Crk-dependent Rap1 activation Lu et al., 2000,) . An involvement of PI3 kinase in NGF-induced Rap1 activation has also been described (York et al., 2000) . PC12 cells also have NGF-and Crk-independent means of activating Rap1 and B-Raf (Vossler et al., 1997; Grewal et al., 2000) . On the other hand, support for the NGF ± TrkA ± Crk ± C3G ± Rap1 ± B-Raf ± MEK ± MAPK cascade model now comes from another study just published (Kao et al., 2001 ).
The FRS2/SNT protein, originally cloned as a Grb2 binding protein involved in FGF-receptor signalling (Kouhara et al., 1997) could be an additional component of this pathway. It was reported to bind to Crk in vitro when extracted from NGF-stimulated cells transfected with TrkA (Meakin et al., 1999) but detailed functional analyses are yet to be done. Another suspect that has surfaced more recently in NGF signalling is c-Abl kinase. Some years ago it was shown that Bcr ± Abl expression induces neurite outhgrowth in PC12 cells (Maru et al., 1996) and last year an interaction of TrkA and c-Abl was reported (Brown et al., 2000; Yano et al., 2000a) . Moreover, results from the Birge laboratory point to a key role of c-Abl in phosphorylating the regulatory tyrosine 221 of c-Crk II (Y222 in the chicken protein; Escalante et al., 2000) .
The availability of DNA chips allows large numbers of genes to be analysed simultaneously for expression. These chips could be used to compare the dierent PC12 clones investigated in those studies and may help to explain some con¯icting results obtained by the dierent research groups. Nevertheless, a better idea may be to move beyond the PC12 cell system and to also look in detail at NGF-responsive primary cells derived from developing animal embryos. Since mice void of the CRKL protein exhibit severe neural pathology, crucial in vivo signalling events mediated by Crk family adaptors may await discovery in these cells.
Knockout' mice
The targeted disruption of the crkl gene locus (Guris et al., 2001 ) was reported just a few month ago. CRKL-de®cient mice show striking defects in neural crest development which mimic to some extent a human neurocristopathy disease known as DiGeorge/ velocardiofacial syndrome (DGS/VCFS). Multiple knockout mouse tissues derived from the cranial and cardiac neural crest cells are aected at dierent stages of embryonic development, which led to the conclusion that CRKL is an essential developmental gene with de®ned stage-and tissue-speci®c roles. Moreover, tissues and organs which depend on neural crest cells for proper development like thymus, thyroid and parathyroid glands and head skeletal structures are also aected. Only a small number of homozygously crkl gene-de®cient mice survive until birth.
Considering the numerous defects resulting from the elimination of the CRKL protein it seems very unlikely that c-Crk and CRKL have redundant functions in mice and that all the observed defects can be simply explained as a`gene dosage change' of Crk family adaptors. The much more likely explanation is that the c-crk and crkl genes are not functionally as similar as one may have guessed from results of biochemical studies looking at Crk and CRKL SH2 and SH3 binding proteins. crkl-knockout mice have also been generated in the laboratory of Nora Heisterkamp and John Groen where the human CRKL was initially found. These mice appear to have a similar but not identical phenotype when compared to the mice generated by Guris et al. (2001) (N Heisterkamp and J Groen, personal communication) .
So far, no mice with a targeted disruption of the crk gene locus have been described. One study generated by gene trap insertional mutagenesis a mouse strain which expresses only a truncated,`c-Crk I-like' Crkprotein, but these mice did not exhibit obvious abnormalities (Imaizumi et al., 1999) .
Crk family adaptors in human disease
There exist only a few reports which indicate that Crk family adaptors could be functionally linked to human diseases. The most obvious example at present is the already discussed connection between CRKL and its binding partners Bcr ± Abl and Tel-Abl in leukaemias. In addition, a mutant c-Ret receptor which causes multiple endocrine neoplasia type 2B (Men 2B) can phosphorylate Crk binding proteins like paxillin which are not prominent substrates of the wildtype c-Ret receptor (Bocciardi et al., 1997) . The functional consequences of these additional substrate phosphorylations are not known. p130Cas ± Crk complexes may also play a role in the infection of epithelial cells by the bacterium Yersinia pseudotuberculosis which causes gastroenteritis (Persson et al., 1997; Weidow et al., 2000) . In the current literature there are many data to indicate that Crk family adaptors are involved in the regulation of biological phenomena like cell morphology changes, cell movement, cell proliferation and dierentiation but also functional responses of the Band T-cell receptors. It is therefore likely that additional hints regarding human diseases which aect or utilise Crk adaptor-mediated signals will be found.
Many open questions
After more than a decade of Crk adaptor protein analyses there are still many more questions than answers. Some important questions not yet pointed out relate to the role of the SH3(2) domain in c-Crk II and CRKL and the possibly quite dierent roles of the cCrk I and c-Crk II proteins. Several laboratories have so far failed to detect proteins or even protein motifs which can stably interact with the SH3(2) domains. As mentioned above, mice which lack full length c-Crk II and only express a truncated c-Crk I-like protein clearly do not have a grossly abnormal phenotype (Imaizumi et al., 1999) . On the other hand, c-Crk I and c-Crk II show clearly dierences in their transforming potency of ®broblast cells (Matsuda et al., 1992) and the p130Cas tyrosine phosphorylation is much greater in cells overexpressing c-Crk I compared to cells overexpressing c-Crk II (Ogawa et al., 1994) . This led to the suggestion that the SH3(2) domain of c-Crk II could serve as a negative regulatory element, but how this might be accomplished is not understood. A new study suggests now that the second SH3 domain of Crk could function as a trans-acting regulatory element for the tyrosine kinases FAK and c-Abl (Zvara et al., 2001) .
Other important questions relate to the targets of Crk-mediated signals downstream of Rap1 and Rac as well as on the level of gene expression. Changes presumably induced in the transcriptional programme of some cells which transmit signals via Crk and CRKL into the nucleus, like signals generated by STAT5 ± CRKL heterodimers are completely unknown.
To¯oat or not to¯oat
In earlier paragraphs it was summarized how Crk family adaptors interact with multiple proteins via their SH2 and SH3 domains. While some complexes appear to be largely constitutive (for example the Crk ± C3G interaction), many Crk/CRKL SH2 domain interactions are clearly inducible and transient. This raises the question whether signalling cascades come into existence somewhat`randomly', which means that their formation is mainly driven by statistical probabilities depending on protein abundancies, binding anities etc. In other words, the question is whether the Crk and CRKL adaptor molecules¯oat freely within the cytosol and are simply ®shed out whenever a receptor or receptor cluster starts to signal. Alternatively, there might be some yet unknown form of higher order which determines whether a preformed Crk ± C3G or a Crk ± DOCK180 complex is recruited in a certain situation. This could occur by restricting the diusion of the Crk ± C3G versus the Crk ± DOCK180 complexes to distinct cellular subregions, through low anity interactions with scaold proteins or by other means. The rapidly accumulating knowledge about cellular ultrastructures, molecular wiring diagrams and their dynamics provides more and more examples of highly ordered biological response systems. Seem-ingly small dierences in proteins through dierential splicing, posttranslational modi®cation etc. may play key roles in these processes. From the recently emerged knowledge about the human genome it is clear that signi®cantly fewer genes than expected exist and that more protein variants are derived from one gene than previously anticipated. It is certainly true for the analysis of Crk family adaptor signalling that dierences between existing splice variants of the involved proteins have so far been hardly looked at.
Do they need to meet?
Another important question is, how crosstalk between Crk-mediated pathways and other pathways occurs and if it is functionally important that multiple Crk/ CRKL molecules and their binding partners are recruited to`intracellular meeting points' like the 15(Y-x-x-P) cluster in p130Cas. In other words: are Crk/CRKL and its binding partners components of large`signalosomes'?
It has become apparent in recent years that many intracellular signalling components are con®ned to speci®c subcellular locations and form large complexes either by interacting with scaold proteins, lipid rafts, microdomains and caveolae or by assembling into multi-protein structures that have been called`signalosomes',`transducisomes' etc. (Kurzchalia and Parton, 1999; Burack and Shaw, 2000; Schillace and Scott, 1999; Simons and Toomre, 2000) . Considering the Crk/ CRKL SH2 binding proteins with numerous Y-x-x-P motifs already known, it is not unlikely that Crk adaptors are important components of such large signal transduction complexes. Studies using overexpression systems of wildtype or mutant Crk/CRKL binding proteins could therefore lead to experimental eects which are dicult to understand in terms of their true biological signi®cance. One possibility to overcome some of the limitations of forced protein expression is the use of small inhibitory molecules which only block the interaction(s) of a single protein domain. Inhibitory molecules for SH2 and SH3 domain binding pockets are currently being developed in the form of cell-penetrating peptides and small compounds (Cody et al., 2000; Kardinal et al., 2000 Kardinal et al., , 2001 . Their usefulness will critically depend on binding anities but also on their ability to block with great selectivity only one or very few of the more than 300 SH2 and SH3 domains which exist in human cells.
Mining the upcoming information from genome sequencing projects
With the ongoing eorts to sequence many vertebrate genomes, it becomes increasingly feasible to obtain a list of new candidate proteins which could recruit Crk family adaptors by simple sequence analysis of publically accessible data bases. This belief is based upon the observation that many Crk/CRKL SH2 binding proteins have multiple Y-x-x-P motifs clustered within a speci®c region of the protein. Examples are the previously discussed proteins of the Cas-, Gab-and IRS-families. Looking through the database, the occurrence of four or more Y-x-x-P motifs per 100 kDa of protein chain length is relatively rare. If one further excludes extracellular proteins from the list, the number of`hits' is not too large. Proteins with a known or suspected function in signal transduction deserve, of course, special attention. The best way to screen the initial candidates for their actual binding properties may be to select or generate cell lines which express the candidate protein plus a constitutively active tyrosine kinase which eciently phosphorylates Y-x-x-P motifs, for example v-Src, v-Abl or Bcr-Abl. Lysates from these cells can then be used to perform co-immunoprecipitation experiments.
By contrast, recognizing good candidates for novel Crk/CRKL SH3(1) domain interacting proteins may not be quite so simple. The currently well known binding proteins have at most four, but usually only one or two binding sites and there are simply too many proteins with a P-x-x-P-x-K motif in the databases to use a simple`one-dimensional' approach. Nevertheless, by taking advantage of the available high resolution structure of the SH3(1) domain (Wu et al., 1995) and information in some cases available on the folding of candidate Crk SH3(1) binding molecules, it may be possible to develop suitable molecular modelling programmes which narrow down the number of preliminary suspects considerably. Last not least, cell types newly implicated by gene knockout studies may be a good ®shing ground to catch novel signalling partners and de®ne yet unknown signalling pathways of Crk family adaptors.
Note added in proof An important new study just documented that insulinstimulated Glut4 glucose transporter translocation requires a Crk ± Cbl complex-mediated signal independently of PI3 kinase ± IRS complexes (Chiang et al., 2000) .
